Premium
P3‐422: A placebo‐controlled pilot discontinuation trial following haloperidol treatment of behavioral and psychotic symptoms in Alzheimer's disease
Author(s) -
Devanand Davangere P.,
Pelton Gregory H.
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1965
Subject(s) - discontinuation , haloperidol , placebo , antipsychotic , medicine , extrapyramidal symptoms , brief psychiatric rating scale , psychosis , psychiatry , psychology , schizophrenia (object oriented programming) , alternative medicine , pathology , dopamine